BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7700989)

  • 21. Effect of SR 27417 on the binding of [3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes.
    Herbert JM; Laplace MC; Cailleau C; Maffrand JP
    J Lipid Mediat; 1993 May; 7(1):57-78. PubMed ID: 8395255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
    Dhar A; Paul AK; Shukla SD
    Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro inhibitory effect of rubraxanthone isolated from Garcinia parvifolia on platelet-activating factor receptor binding.
    Jantan I; Pisar MM; Idris MS; Taher M; Ali RM
    Planta Med; 2002 Dec; 68(12):1133-4. PubMed ID: 12494345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PAF binding to a single receptor in corneal epithelium plasma membrane.
    Hurst J; Ma X; Bazan HE
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):790-5. PubMed ID: 10067986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
    Hwang SB; Lam MH; Alberts AW; Bugianesi RL; Chabala JC; Ponpipom MM
    J Pharmacol Exp Ther; 1988 Aug; 246(2):534-41. PubMed ID: 2841449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piperbetol, methylpiperbetol, piperol A and piperol B: a new series of highly specific PAF receptor antagonists from Piper betle.
    Zeng HW; Jiang YY; Cai DG; Bian J; Long K; Chen ZL
    Planta Med; 1997 Aug; 63(4):296-8. PubMed ID: 9270371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of platelet agonists on the binding of platelet-activating factor to human platelets.
    Burgers JA; Akkerman JW
    J Lipid Mediat; 1992 Sep; 5(3):289-300. PubMed ID: 1334723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for the presence of specific high affinity cytosolic binding sites for platelet-activating factor in human neutrophils.
    Svetlov S; Nigam S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):162-6. PubMed ID: 8380690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antagonistic effect of hydroxysafflor yellow A on the platelet activating factor receptor].
    Zang BX; Jin M; Si N; Zhang Y; Wu W; Piao YZ
    Yao Xue Xue Bao; 2002 Sep; 37(9):696-9. PubMed ID: 12567893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
    Lakin KM; Kulikov VI; Manevich EM; Muliar AG; Shvets VI
    Farmakol Toksikol; 1988; 51(4):113-23. PubMed ID: 2847936
    [No Abstract]   [Full Text] [Related]  

  • 31. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Properties of the guinea-pig lung platelet-activating factor receptor encoded by the cloned cDNA.
    Honda Z; Nakamura M; Seyama Y; Shimizu T
    J Lipid Mediat; 1992; 5(2):105-7. PubMed ID: 1326344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rabbit blastocysts accumulate platelet-activating factor (PAF) and lyso-PAF in vitro.
    Jones MA; Kudolo GB; Harper MJ
    Mol Reprod Dev; 1992 Jul; 32(3):243-50. PubMed ID: 1323306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition by glaucocalyxin A of aggregation of rabbit platelets induced by ADP, arachidonic acid and platelet-activating factor, and inhibition of [3H]-PAF binding.
    Bin Z; Kun L
    Thromb Haemost; 1992 Apr; 67(4):458-60. PubMed ID: 1631795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occupancy of platelet receptors for platelet-activating factor in patients with septicemia.
    Lopez Diez F; Nieto ML; Fernandez-Gallardo S; Gijon MA; Sanchez Crespo M
    J Clin Invest; 1989 May; 83(5):1733-40. PubMed ID: 2540221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding.
    Herbert JM; Laplace MC; Maffrand JP
    J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet activating factor antagonist activity of ginsenosides.
    Jung KY; Kim DS; Oh SR; Lee IS; Lee JJ; Park JD; Kim SI; Lee HK
    Biol Pharm Bull; 1998 Jan; 21(1):79-80. PubMed ID: 9477174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of compounds from Goniothalamus tapis Miq. and Goniothalamus uvaroides King on platelet-activating factor receptor binding.
    Moharam BA; Jantan I; Jalil J; Ahmad F
    Phytother Res; 2012 May; 26(5):687-91. PubMed ID: 22002630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-activating factor (PAF) antagonistic activity of a new biflavonoid from Garcinia nervosa var. pubescens King.
    Jalil J; Jantan I; Ghani AA; Murad S
    Molecules; 2012 Sep; 17(9):10893-901. PubMed ID: 22964504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pinusolide from the leaves of Biota orientalis as potent platelet activating factor antagonist.
    Kim KA; Moon TC; Lee SW; Chung KC; Han BH; Chang HW
    Planta Med; 1999 Feb; 65(1):39-42. PubMed ID: 10083843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.